Request a copy

Full Text

• Pittens, CACM, Elberse, JE, Visse, M, Abma, TA, Broerse, JEW, Research agendas involving patients: factors that facilitate or impede translation of patients' perspectives in programming and implementation. Sci Public Policy 41 (2014), 809–820.
• de Wit, M, Kirwan, JR, Tugwell, P, et al. Successful stepwise development of patient research partnership: 14 years' experience of actions and consequences in Outcome Measures in Rheumatology (OMERACT). Patient 10 (2017), 141–152.
• Pushparajah, D, Geissler, J, Westergaard, N, EUPATI: collaboration between patients, academia and industry to champion the informed patient in the research and development of medicines. J Med Dev Sci 1 (2015), 74–80.
• European Medicines Agency. Outcome report on pilot to involve patients in benefit/risk discussions at CHMP meetings. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2017/05/WC500227335.pdf, 2017. (Accessed 21 November 2018)
• US Food and Drug Administration. Patient-focused drug development guidance public workshop: methods to identify what is important to patients & select, develop or modify fit-for-purpose clinical outcomes assessments. https://www.fda.gov/downloads/Drugs/NewsEvents/UCM620708.pdf, 2018. (Accessed 21 November 2018)
• Hewlett, S, de Wit, M, Richards, P, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum 55 (2006), 676–680.
• Tunis, SR, Maxwell, LJ, Graham, ID, et al. Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets. J Rheumatol 44 (2017), 1551–1559.
• De Wit, M, Beurskens, A, Piškur, B, Stoffers, E, Moser, A, Preparing researchers for patient and public involvement in scientific research: development of a hands-on learning approach through action research. Health Expect 21 (2018), 752–763.